ArticleslgStudy

chemistry

Oveporexton

Oveporexton is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Oveporexton rather than just read about it. In short: Oveporexton, sold under the brand name Orzeyful, is a medication used for the treatment of narcolepsy type 1. It is taken by mouth.

Oveporexton — main illustration
Oveporexton — illustration

Key takeaways

  • Oveporexton belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Oveporexton to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Oveporexton from memory before moving on to harder problems.

Reference excerpt

Oveporexton, sold under the brand name Orzeyful, is a medication used for the treatment of narcolepsy type 1. It is taken by mouth. The most common side effects include insomnia, increased urinary frequency, urgency to urinate, and increased saliva production. Oveporexton is an orexin OX2 receptor agonist. Oveporexton was approved for medical use in China in July 2026, and in the United States in August 2026. It is recommended for scheduling under the Controlled Substances Act and will be lawful to market in the US following the scheduling decision issued by the Drug Enforcement Administration.

Medical uses Oveporexton is indicated for the treatment of narcolepsy type 1 (narcolepsy with cataplexy) in adults. Narcolepsy type 1 is a rare, lifelong neuropsychiatric sleep disorder. It is caused by the loss of brain cells that produce orexin, a chemical messenger that regulates wakefulness, sleep, and muscle tone. Without orexin, the brain struggles to maintain alertness or to control the boundary between sleep and waking. The result is a cluster of disabling symptoms, including excessive daytime sleepiness, cataplexy (sudden muscle weakness triggered by strong emotions such as laughter), sleep paralysis, hallucinations at the edge of sleep or waking, and disrupted nighttime sleep. The effectiveness and safety of oveporexton were evaluated in two randomized, double-blind, placebo-controlled 12-week studies enrolling 273 adults with narcolepsy type 1. Across both studies, participants taking oveporexton 2 mg showed improvements in their ability to stay awake during the day compared with those receiving placebo. Participants also reported substantially less daytime sleepiness, a significant reduction in cataplexy episodes, and meaningful improvement across the full spectrum of narcolepsy symptoms, including sleep paralysis, hallucinations, and disrupted nighttime sleep.

Contraindications The only listed absolute contraindication of oveporexton is combination with strong CYP3A4 inhibitors.

Side effects The most common side effects of oveporexton include insomnia, increased urinary frequency, urgency to urinate, and increased saliva production.

Overdose There is no specific antidote for oveporexton overdose.

Interactions Oveporexton is primarily metabolized by the cytochrome P450 enzyme CYP3A4. As such, CYP3A4 inhibitors and inducers can alter oveporexton exposure and hence result in interactions when combined with oveporexton. Strong CYP3A4 inhibitors are contraindicated with oveporexton, while dose reduction is warranted with moderate CYP3A4 inhibitors. Use with moderate to strong CYP3A4 inducers should be avoided. No clinically meaningful interactions are expected with weak CYP3A4 inhibitors and inducers. Examples of moderate to strong CYP3A4 inhibitors include itraconazole and fluconazole. Examples of moderate to strong CYP3A4 inducers include phenytoin. Oveporexton does not appear to inhibit or induce various cytochrome P450 enzymes itself.

Pharmacology

Pharmacodynamics Oveporexton acts as a selective agonist of the orexin OX2 receptor. Oveporexton has wakefulness-promoting effects in animals, including in rodents and monkeys. In addition, oveporexton has been found to be effective in the treatment of narcolepsy and cataplexy in phase 3 clinical trials in humans. Oveporexton is a first-in-class medication and targets the root symptomatic cause of narcolepsy type 1 by remediating the orexin (hypocretin) deficiency that is present in the condition.

Pharmacokinetics The disposition of oveporexton is biexponential and it has an elimination half-life of 16 to 24 hours in humans. The FDA label gives a more specific mean terminal elimination half-life of 23.2 hours.

History Oveporexton was developed by Takeda. As of July 2025, it has completed phase III clinical trials for treatment of narcolepsy. Oveporexton was approved in China for narcolepsy type 1 in July 2026, its first global approval. Oveporexton was approved in the United States for narcolepsy type 1 in August 2026.

Society and culture

Names Oveporexton is the international nonproprietary name and the United States Adopted Name. It is sold under the brand name Orzeyful.

Legal status Oveporexton was approved for medical use in China in July 2026, and in the United States in August 2026. The FDA granted the application for oveporexton breakthrough therapy and priority review designations. The approval of Orzeyful for the treatment of narcolepsy type 1 was granted to Takeda Pharmaceuticals America. Oveporexton is recommended for scheduling under the Controlled Substances Act and will be lawful to market in the US following the scheduling decision issued by the Drug Enforcement Administration.

References

Further reading Kallweit MS, Kallweit NP, Kallweit U (29 November 2023). "Pharmacological Treatments of Sleep–Wake Disorders: Update 2023". Clinical and Translational Neuroscience. 7 (4): 42. doi:10.3390/ctn7040042. hdl:20.500.12512/242676. ISSN 2514-183X. Kornum BR, Breum AW, Mincikiewicz Z, Knudsen-Heier S (July 2026). "Therapeutic potential of targeting the orexin (hypocretin) system in sleep disorders". Nat Rev Endocrinol. doi:10.1038/s41574-026-01277-2. PMID 42533134.

External links Clinical trial number NCT06470828 for "A Study of TAK-861 for the Treatment of Narcolepsy Type 1" at ClinicalTrials.gov Clinical trial number NCT06505031 for "A Study of TAK-861 in People With Narcolepsy Type 1" at ClinicalTrials.gov

Illustrations

Oveporexton illustration

Worked examples

Example 1 — a first encounter with Oveporexton

Start with the simplest possible case. Write down what Oveporexton claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Oveporexton before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Oveporexton ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Oveporexton

In research
Oveporexton appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Oveporexton in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Oveporexton is common in secondary-school and first-year university syllabi. It links to neighbouring topics 3,5-Difluorophenyl compounds, Carboxamides, Fluoroarenes, so understanding it makes those chapters shorter.
In everyday life
Look for Oveporexton outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Oveporexton” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Oveporexton in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Oveporexton means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Oveporexton out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Oveporexton in simple terms?

Oveporexton, sold under the brand name Orzeyful, is a medication used for the treatment of narcolepsy type 1. It is taken by mouth.

Why does Oveporexton matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Oveporexton?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Oveporexton.

Tags

  • 3,5-Difluorophenyl compounds
  • Carboxamides
  • Fluoroarenes
  • Orexin receptor agonists
  • Pyrrolidines
  • Sulfonamides
  • Tertiary alcohols
  • Wakefulness-promoting agents

Keep exploring